CD4 (Domain 1) Antibody, anti-rat, PE, REAfinity™ 130-107-668 from Miltenyi Biotec | Biocompare.com

(1)

Citations:

Supplier Page from
Miltenyi Biotec for
CD4 (Domain 1) Antibody, anti-rat, PE, REAfinity™

Miltenyi Biotec's CD4 (Domain 1) Antibody, anti-rat, PE, REAfinity™ is a Human monoclonal antibody. The CD4 (Domain 1) Antibody, anti-rat, PE, REAfinity™ was generated using CD4 as the antigen. It reacts with Rat. This antibody has been shown to work in applications such as: Flow Cytometry.

Product Specs
ItemCD4 (Domain 1) Antibody, anti-rat, PE, REAfinity™
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-107-668
Quantity9 µg in 300 µL
ApplicationsFlow cytometry
Conjugate/TagPE
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
IsotypeIgG1
CloneREA482
Hosthuman cell line
Antibody TypePrimary antibodies, Recombinant antibodies
NCBI Full Gene NameCd4 molecule
NCBI Gene AliasesW3/25, p55
Clonalitymonoclonal
Reactivityrat
Concentration1:10
ModificationsRecombinantly engineered
TargetCD4 (Domain 1)
Research AreaFor research use only
Regulatory StatusFor research use only

Add to Compare List

Miltenyi Biotec

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) CD4+CD25+Foxp3+ T cells contribute to the antiasthmatic effects of Astragalus membranaceus extract in a rat model of asthmaInternational immunopharmacologyJanuary 1, 2013Jin H, Luo Q, Zheng Y, Nurahmat M, Wu J, Li B, Lv Y, Wang G, Duan X, Dong J.

(2) CD4 microglial expression correlates with spontaneous clinical improvement in the acute Lewis rat EAE modelJournal of neuroimmunologyApril 30, 2009Almolda B, Costa M, Montoya M, González B, Castellano B.

(3) Peptide and nucleotide sequences of rat CD4 (W3/25) antigen: evidence for derivation from a structure with four immunoglobulin-related domainsProceedings of the National Academy of Sciences of the United States of AmericaMarch 1, 1987Clark SJ, Jefferies WA, Barclay AN, Gagnon J, Williams AF.

(1)

3/24/2016Good Separation of CD4 Population Jesus Cirizawe analyzied CD 4 and CD8 population on lymph nodes . We chose milteny antibodies and got good results.